Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Usefulness of immunocytochemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients.

× No keyword cloud information.

17 in total

1. Immunohistochemistry as a quick screening method for clinical detection of BRAF(V600E) mutation in melanoma patients.

Authors: Qiongrong Chen; Chunjiao Xia; Yunte Deng; Mingwei Wang; Ping Luo; Changming Wu; Junqiu Yue; Na Fang; Manxiang Wang; Shaozhong Wei
Journal: Tumour Biol Date: 2014-02-23

2. Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Authors: Sophie Laget; Lucile Broncy; Katia Hormigos; Dalia M Dhingra; Fatima BenMohamed; Thierry Capiod; Magne Osteras; Laurent Farinelli; Stephen Jackson; Patrizia Paterlini-Bréchot
Journal: PLoS One Date: 2017-01-06 Impact factor: 3.240

Review 3. Pathologists and liquid biopsies: to be or not to be?

Authors: Paul Hofman; Helmut H Popper
Journal: Virchows Arch Date: 2016-08-23 Impact factor: 4.064

Review 4. Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives.

Authors: Hisashi Kanemaru; Yukari Mizukami; Akira Kaneko; Ikko Kajihara; Satoshi Fukushima
Journal: Curr Treat Options Oncol Date: 2022-03-17

Review 5. Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?

Authors: Marius Ilie; Véronique Hofman; Elodie Long; Olivier Bordone; Eric Selva; Kevin Washetine; Charles Hugo Marquette; Paul Hofman
Journal: Ann Transl Med Date: 2014-11

Usefulness of immunocytochemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients.

1. Immunohistochemistry as a quick screening method for clinical detection of BRAF(V600E) mutation in melanoma patients.

2. Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Review 3. Pathologists and liquid biopsies: to be or not to be?

Review 4. Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives.

Review 5. Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?

Review 6. Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential.

Review 7. Circulating tumor cell isolation: the assets of filtration methods with polycarbonate track-etched filters.

8. NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.

9. Circulating Tumor Cell Detection and Capture by Photoacoustic Flow Cytometry in Vivo and ex Vivo.

10. Circulating Tumor Cells: Who is the Killer?